NCT01084564

Brief Summary

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2008

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 10, 2010

Completed
Last Updated

March 10, 2010

Status Verified

March 1, 2010

Enrollment Period

5 months

First QC Date

March 9, 2010

Last Update Submit

March 9, 2010

Conditions

Heart FailureAsthma

Keywords

Cost-effectiveness analysisColombia

Outcome Measures

Primary Outcomes (2)

  • To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia

    12 months

  • Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives

Study Arms (1)

1

moderate to severe uncontrolled asthma

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Moderate to severe uncontrolled asthma.

You may qualify if:

  • Asthma moderate to severe.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart FailureAsthma

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Rodolfo Dennis, M.D.

    Pontificia Universidad Javeriana

    STUDY DIRECTOR

  • MARÍA XIMENA ROJAS, M.D.

    Pontificia Universidad Javeriana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

March 9, 2010

First Posted

March 10, 2010

Study Start

January 1, 2008

Primary Completion

June 1, 2008

Study Completion

June 1, 2008

Last Updated

March 10, 2010

Record last verified: 2010-03